NCT03448042 2026-02-27A Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing CancersGenentech, Inc.Phase 1 Active not recruiting123 enrolled
NCT03539484 2020-09-03A Study of RO7172508 in Patients With Locally Advanced and/or Metastatic CEA-Positive Solid TumorsHoffmann-La RochePhase 1 Terminated26 enrolled 30 charts